Senior Executive-Engineering

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to customers across geographies. The business is structured into two segments: Specialty Pharmaceuticals and Generics & APIs. Specialty Pharmaceuticals includes Radiopharmaceuticals, Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products. Generics & APIs includes Solid Dosage Formulations & Active Pharmaceutical Ingredients. Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma with Research & Development units in Noida and Mysore, India. It operates manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, engaged in APIs and Dosage manufacturing, respectively. The Mysore manufacturing site, spread over 69 acres, is USFDA approved and focuses on Lifestyle driven Therapeutic Areas like CVS and CNS. It is a market leader in four APIs and among the top three players for three others. The Roorkee facility is state-of-the-art, approved by multiple regulatory bodies, and works on a B2B model for EU, Canada, and emerging markets. Both manufacturing units are supported by around 500 research and development professionals based at Noida and Mysore. The R&D focuses on developing new products in API, Solid Dosage Formulations, Sterile Injectable, Semi-Solids, Ointments, Creams, and Liquids. All BA/BE studies are conducted in-house at an 80 Bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals ensure a unique portfolio of patents and product filings in regulatory and non-regulatory markets. The revenue of Jubilant Pharma has been increasing, with INR 53,240 Million in the Financial Year 2018 -19 compared to INR 39,950 Million in 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,